Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online March 15, 2007
Diabetes Care 30:1579-1580, 2007
DOI: 10.2337/dc06-2568
© 2007 by the American Diabetes Association
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-2568v1
30/6/1579    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herranz, L.
Right arrow Articles by Pallardo, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herranz, L.
Right arrow Articles by Pallardo, L. F.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Clinical Care/Education/Nutrition
Brief Report

Non–Glycemic-Dependent Reduction of Late Pregnancy A1C Levels in Women With Type 1 Diabetes

Lucrecia Herranz, MD1, Lourdes Saez-de-Ibarra, BSC1, Cristina Grande, SCD2 and Luis F. Pallardo, MD1

1 Department of Endocrinology, Hospital La Paz, Madrid, Spain
2 Department of Biochemistry, Hospital La Paz, Madrid, Spain

Address correspondence and reprint requests to Lucrecia Herranz, Unidad de Diabetes, Hospital Universitario La Paz, Paseo de la Catellana 261, 28046 Madrid, Spain. E-mail: lucherranz.hulp{at}salud.madrid.org


   INTRODUCTION
TOP
 INTRODUCTION
RESEARCH DESIGN AND METHODS--
 RESULTS--
 CONCLUSIONS--
 References
 
Areduction of A1C levels during pregnancy in women without diabetes has been reported (1–6), suggesting that the goal for A1C during pregnancy complicated with diabetes should be lowered. The decrease in fasting blood glucose levels during the first trimester of normal pregnancy (7,8) may explain the lower A1C levels found in early pregnancy (1,2,3,5). A further decrease of A1C in late pregnancy in women without diabetes has been reported by Nielsen et al. (3), which may be related to decreased erythrocyte life span (9,10).

In women with type 1 diabetes, strict glycemic control during pregnancy leads to a reduction in A1C levels, which may be insufficient to prevent the complications of pregnancy in type 1 diabetes (11,12). Since the decrease in A1C during normal pregnancy is related to lower blood glucose and to decreased erythrocyte lifespan (6–10), some of the reduction of A1C observed in pregnant women with type 1 diabetes will not be related to improved glycemic control. Therefore, A1C levels in pregnancies complicated by diabetes can be misleading when evaluating the degree of glycemic control. The aim of this study was to quantify the decrease in A1C levels during late pregnancy in women with type 1 diabetes who were not dependent on glycemic control.


   RESEARCH DESIGN AND METHODS—
TOP
 INTRODUCTION
 RESEARCH DESIGN AND METHODS--
RESULTS--
 CONCLUSIONS--
 References
 
This study was performed at the Hospital Universitario La Paz, Madrid, Spain. Ethical approval for this research was provided by the hospital's ethical committee, and all women gave their informed consent.

From our Diabetes and Pregnancy Unit, we selected 68 women with type 1 diabetes, aged 32.0 ± 3.0 years, with diabetes duration 14.6 ± 7.5 years and prepregnancy BMI 24.6 ± 3.4 kg/m2, who performed home blood glucose monitoring using the same type of glucose meter (OneTouch profile; LifeScan, Milpitas, CA) from at least 3 months before conception and throughout pregnancy. All women were on flexible basal bolus insulin regimens and were trained to adjust their insulin dose.

Glucose readings stored in the meter were downloaded to a computer (diabetes management software In Touch; LifeScan) at each visit. Mean glucose levels were obtained from the glucose readings for the 12 weeks before conception (preconception) and for the third trimester (from 25 gestational weeks to 36 complete gestational weeks). The mean number of glucose readings per day was 4.3 for preconception and 5.6 for third trimester. A1C was measured in EDTA-anticoagulated fresh blood samples, using a high-performance liquid chromatography DCCT (Diabetes Control and Complications Trial)-aligned method (Variant II HPLC analyzer; BioRad, Richmond, VA). The A1C reference intervals are 4–6%, and the interassay precision coefficient of variation for control materials with a DCCT-assigned A1C content of 5.3 and 9.6% is 2.1 and 2%, respectively. The A1C levels included in this study were the last measurement during preconception (nearest to conception) and the measurement nearest to 36 weeks' gestation.

Statistical analyses were conducted using SPSS version 8.0 statistical software (SPSS, Chicago, IL). To compare mean values among quantitative variables, the paired-samples Student's t test was used. Pearson correlation coefficient was used to measure the linear relation between A1C and mean glucose. Multivariate linear regression analysis was performed to estimate the effect of pregnancy on the relation between A1C and mean glucose. In this model, the dependent variable was A1C and the independent variables were mean glucose and pregnancy status. Pregnancy status was coded as a categorical variable (preconception = 0; third trimester = 1). Glucose and A1C are reported as means ± SD. A P value <0.05 was considered significant.


   RESULTS—
TOP
 INTRODUCTION
 RESEARCH DESIGN AND METHODS--
 RESULTS--
CONCLUSIONS--
 References
 
Preconception mean glucose was 138.9 ± 17.9 mg/dl (range 88; median 140.5), and preconception A1C was 6.6 ± 0.6% (range 2.9; median 6.6), with a significant correlation between them (r = 0.648; P < 0.001). Third trimester mean glucose was 129.0 ± 13.1 mg/dl (range 48; median 129), and third trimester A1C was 6.0 ± 0.5% (range 2.2; median 6.1), with a significant correlation between them (r = 0.580; P < 0.001). There was a significant decrease both in mean glucose and in A1C (P < 0.005) from preconception to third trimester. The regression equation to predict A1C from mean glucose and pregnancy status was: A1C = 3.66 + (0.02 x mean glucose) + (–0.38 x pregnancy status). The R2 of the model was 0.531 (P < 0.001). The SE for the constant was 0.33, and the SEs for the ß-coefficients for mean glucose and pregnancy status were 0.02 and 0.08, respectively. Figure 1 shows the regression lines for the relation between A1C and mean glucose before pregnancy (pregnancy status = 0) and in late pregnancy (pregnancy status = 1).


Figure 1
View larger version (21K):
[in this window]
[in a new window]

  		Figure 1— Regression lines for the relation between A1C and mean glucose before pregnancy and in late pregnancy.

 

   CONCLUSIONS—
TOP
 INTRODUCTION
 RESEARCH DESIGN AND METHODS--
 RESULTS--
 CONCLUSIONS--
References
 
From our data, the regression line to predict third trimester A1C (pregnancy status = 1) would be: A1C = 3.66 + (0.02 x mean glucose) – 0.38, while the regression line to predict preconception A1C (pregnancy status = 0) would be: A1C = 3.66 + (0.02 x mean glucose). This means that in women with type 1 diabetes, a reduction of ~0.4% in the A1C value can be expected in late pregnancy, which is not dependent on mean glucose levels. Figure 1 shows that for any mean glucose value, the A1C predicted will be lower in late pregnancy than before pregnancy (e.g., for a mean glucose of 140 mg/dl, the A1C would be 6.5% before pregnancy and 6.1% in late pregnancy).

Biological variation in A1C, which is distinct from that attributable to mean glucose, cannot account for the change observed. Variation of A1C between individuals, which represents the main source of A1C variation (11), does not influence our results, since the same women were studied before pregnancy and during pregnancy. Within-individual changes in A1C are too small (12) to explain a reduction of 0.4% in A1C.

Our results provide an additional explanation to the fact that near-normal A1C is insufficient for preventing diabetes-related complications of pregnancy (13,14), since the A1C value will be lower independently of glycemic control. While it seems difficult to achieve the glucose levels reported in healthy pregnant women (15), it is of clinical importance to note that when evaluating third trimester A1C levels in women with type 1 diabetes the value will be ~0.4% lower, without any improvement in glycemic control.

Several studies suggest that the normal upper reference range of A1C in pregnant women should be lower (1–3). Since in women with type 1 diabetes a decrease in third trimester A1C value will occur regardless of glycemic control, we conclude that the A1C goal in late pregnancy should be lowered 0.4% for pregnancies complicated with diabetes.


   Footnotes
 
Published ahead of print at http://care.diabetesjournals.org on 15 March 2007. DOI: 10.2337/dc06-2568.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

Received for publication December 19, 2006. Accepted for publication March 4, 2007.


   References
TOP
 INTRODUCTION
 RESEARCH DESIGN AND METHODS--
 RESULTS--
 CONCLUSIONS--
 References
 

  1. Mosca A, Paleari R, Dalfrà MG, Di CianniG, Cuccuru I, Pellegrini G, Mallogi L, Bonomo M, Granata S, Ceriotti F, Castiglioni MT, Songini M, Tocco G, Masin M, Plebani M, Lapolla A: Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 52:1138–1143, 2006[Abstract/Free Full Text]
  2. Radder JK, van Roosmalen J: HbA1c in healthy pregnant women. Neth J Med 63:256–259, 2005[Medline]
  3. Nielsen LR, Ekbom P, Damm P, Glümer C, Frandsen MM, Jensen DM, Mathiesen ER: HbA1c levels are significantly lower in early and late prenancy. Diabetes Care 27:1200–1201, 2004[Free Full Text]
  4. O'Kane MJ, Lynch PLM, Moles KW, Magee SE: Determination of a diabetes control and complications trial-aligned HbA(1c) reference range in pregnancy. Clin Chim Acta 311:157–159, 2001[Medline]
  5. Hartland AJ, Smith JM, Clark PM, Webber J, Chowdhury T, Dunne F: Establishing trimester-and ethnic group-related reference ranges for fructosamine and HbA1c in non-diabetic pregnant women. Ann Clin Biochem 36:235–237, 1999[Medline]
  6. Pettit DJ, Venkat Narayan KM: Glycosylated hemoglobin in pregnancy (Letter). Diabetes Care 19:1455, 1996[Medline]
  7. Mills JL, Jovanovic Y, Knopp R, Aarons J, Conley M, Park E, Lee YJ, Holmes L, Simpson JL, Metzger B: Physiological reduction in fasting plasma glucose concentration in the first trimester of pregnancy: the Diabetes in Early Pregnancy Study. Metabolism 47:1140–1144, 1998[Medline]
  8. Cousins L, Rigg L, Hollingsworth D, Brink G, Aurand J, Yenn SSC: the 24-hour excursion and diurnal rhythm of glucose, insulin and C-peptide in normal pregnancy. Am J Obstet Gynecol 136:483–488, 1980[Medline]
  9. Lurie S, Danon D: Life span of erythrocytes in late pregnancy. Obstet Gynecol 80:123–126, 1992[Abstract/Free Full Text]
  10. Lurie S: Age distribution of erythrocyte population in late pregnancy. Gynecol Obstet Invest 30:147–149, 1990[Medline]
  11. Kilpatrick ES: HbA1c measurement. J Clin Pathol 57:344–345, 2004[Free Full Text]
  12. Kilpatrick ES, Maylor PW, Keevil BG: Biological variation of glycated hemoglobin. Diabetes Care 21:261–264, 1998[Abstract]
  13. Evers IM, de Valk HW, Visser GHA: Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915–918, 2004[Abstract/Free Full Text]
  14. Evers IM, de Valk HW, Mol BWJ, ter Braak EWMT, Visser GHA: Macrosomia despite good glycaemic control in type 1 diabetic pregnancy; results of a nationwide study in the Netherlands. Diabetologia 45:1484–1489, 2002[Medline]
  15. Parretti E, Mecacci F, Papini M, Cioni R, Carignani L, Mignosa M, La Torre P, Mello M: Third-trimester maternal glucose levels from diurnal profiles in non diabetic pregnancies. Diabetes Care 24:1319–1323, 2001[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-2568v1
30/6/1579    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herranz, L.
Right arrow Articles by Pallardo, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herranz, L.
Right arrow Articles by Pallardo, L. F.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum